You are here

Article Text

Article menu

Download PDFPDF

XML
Abstracts from the 5th International Society for Evidence-Based Healthcare Congress, Kish Island, Iran
Poster
146: THE PREVALENCE OF HUMAN PAPILLOMA VIRUS AND ITS HIGH RISK GENOTYPES AMONG IRANIAN HEALTHY WOMEN: A SYSTEMATIC REVIEW AND META-ANALYSIS
  1. Mina Malary1,
  2. Mahmood Moosazadeh2,
  3. Zeinab Hamzehgardeshi3,
  4. Mahdi Afshari4,
  5. Iman Moghaddasifar1,
  6. Amin Afsharimoghadam5
  1. 1Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
  2. 2Assistant Professor, Health Sciences Research Center, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran
  3. 3Assistant Professor, Department of Reproductive Health and Midwifery, School of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari, Iran
  4. 4Department of Community Medicine, Zabol University of Medical Sciences, Zabol, Iran
  5. 5Assistant professor, Zabol University of Medical Sciences, Zabol, Iran.

Abstract

Background and aims: Human papilloma virus (HPV) is the most common sexual transmitted infection worldwide among women and plays a key role in the development of genital cancers. Different studies in Iran, reported various prevalences and combining their results could be important for health policy makers. The aim of this study is to estimate the prevalence of HPV and its high risk genotypes among Iranian healthy women.

Methods: Using national and international databases and excluding duplicates and irrelevant evidences followed by applying exclusion criteria and quality assessment, eligible articles were selected. Standard error of the prevalence was calculated based on binomial distribution. Random effects model was used because of the high heterogeneity among the results.

Results: Of 14 studies entered into the systematic review, 24 evidences reported the HPV prevalence among 7655 healthy and non-cancerous women in different provinces of Iran. Total prevalence of HPV, 9.4% (95% CI: 6.8–12.02), HPV 16, 2.03% (95% CI: 1.3–2.8), HPV 18, 1.7% (95% CI: 0.9–2.5) and other genotypes of HPV, 5.3% (95% CI: 3.6–6.9) were estimated.

Conclusion: Our meta- analysis showed that the total prevalence of HPV and its high- risk genotypes (16 and 18) among healthy non- cancerous Iranian women was very high.

  • Papillomavirus
  • IgG
  • IgM
  • Primary infection
  • prevalence.

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

http://dx.doi.org/10.1136/bmjopen-2016-015415.146

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.